PAPER Gu Z, Yakel JL
SEARCH RESULTS
329938 RESULTS
PAPER Matsumoto SE, Tabira T
[Current trend of immunotherapy for Alzheimer's disease].
Nihon Rinsho. 2011 Sep;69(9):1628-32. PubMed: 21922765PAPER Habtemariam S
The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer's disease therapy.
Nat Prod Commun. 2011 Aug;6(8):1089-90. PubMed: 21922905PAPER Gleichgerrcht E, Roca M, Manes F, Torralva T
Comparing the clinical usefulness of the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS) and the Frontal Assessment Battery (FAB) in frontotemporal dementia.
J Clin Exp Neuropsychol. 2011 Nov;33(9):997-1004. PubMed: 21923634PAPER Ganguli M, Rodriguez E
Age, Alzheimer's disease, and the big picture.
Int Psychogeriatr. 2011 Dec;23(10):1531-4. PubMed: 21923959PAPER Heun R, Schoepf D, Potluri R, Natalwala A
Alzheimer's disease and co-morbidity: Increased prevalence and possible risk factors of excess mortality in a naturalistic 7-year follow-up.
Eur Psychiatry. 2011 Sep 14; PubMed: 21924588PAPER Caraci F, Bosco P, Signorelli M, Spada RS, Cosentino FI, Toscano G, Bonforte C, Muratore S, Prestianni G, Panerai S, Giambirtone MC, Gulotta E, Romano C, Salluzzo MG, Nicoletti F, Copani A, Drago F, Aguglia E, Ferri R
The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression.
Eur Neuropsychopharmacol. 2011 Sep 14; PubMed: 21924590PAPER Lee I, Ahn B, Choi J, Hattori M, Min B, Bae K
Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum.
Bioorg Med Chem Lett. 2011 Nov 1;21(21):6603-7. PubMed: 21924611PAPER Rosini M, Simoni E, Bartolini M, Tarozzi A, Matera R, Milelli A, Hrelia P, Andrisano V, Bolognesi ML, Melchiorre C
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.
Eur J Med Chem. 2011 Nov;46(11):5435-42. PubMed: 21924801PAPER Masuda Y, Fukuchi M, Yatagawa T, Tada M, Takeda K, Irie K, Akagi K, Monobe Y, Imazawa T, Takegoshi K
Solid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid β-protein fibrils.
Bioorg Med Chem. 2011 Oct 15;19(20):5967-74. PubMed: 21924918PAPER Babiloni C, De Pandis MF, Vecchio F, Buffo P, Sorpresi F, Frisoni GB, Rossini PM
Cortical sources of resting state electroencephalographic rhythms in Parkinson's disease related dementia and Alzheimer's disease.
Clin Neurophysiol. 2011 Dec;122(12):2355-64. PubMed: 21924950PAPER Vellas B, Aisen PS, Sampaio C, Carrillo M, Scheltens P, Scherrer B, Frisoni GB, Weiner M, Schneider L, Gauthier S, Gispen-de Wied CC, Hendrix S, Feldman H, Cedarbaum J, Petersen R, Siemers E, Andrieu S, Prvulovic D, Touchon J, Hampel H
Prevention trials in Alzheimer's disease: an EU-US task force report.
Prog Neurobiol. 2011 Dec;95(4):594-600. PubMed: 21925234PAPER Anekonda TS, Quinn JF
Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.
Biochim Biophys Acta. 2011 Dec;1812(12):1584-90. PubMed: 21925266PAPER Hook V, Funkelstein L, Wegrzyn J, Bark S, Kindy M, Hook G
Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.
Biochim Biophys Acta. 2012 Jan;1824(1):89-104. PubMed: 21925292PAPER Silbert B, Evered L, Scott DA
Cognitive decline in the elderly: is anaesthesia implicated?
Best Pract Res Clin Anaesthesiol. 2011 Sep;25(3):379-93. PubMed: 21925403Current Filters
No filters selected